Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™ July 1, 2024July 1, 2024 Max Mallet
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma June 28, 2024October 29, 2024 Ajit Muley
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption June 28, 2024June 28, 2024 Ajit Muley
Can a simple blood test tell you how your cancer therapy works? March 29, 2024March 29, 2024 Ajit Muley
Exploring the Impact of Substance Use on Cancer Immunotherapy March 22, 2024March 22, 2024 Max Mallet